Advertisement

Topics

No difference in toxicity for 6-, 2-fraction HDR in prostate cancer

10:00 EDT 7 Sep 2017 | Medical Xpress

(HealthDay)—For men with prostate cancer there is no difference in acute genitourinary or sexual dysfunction between 6- and 2-fraction high-dose-rate (HDR) brachytherapy monotherapy, according to a study published online Aug. 29 in the Journal of Medical Imaging and Radiation Oncology.

Original Article: No difference in toxicity for 6-, 2-fraction HDR in prostate cancer

NEXT ARTICLE

More From BioPortfolio on "No difference in toxicity for 6-, 2-fraction HDR in prostate cancer"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Sexual Health
The World Health Organization (WHO) definition of sexual health; "the state of physical, emotional, mental and social well-being related to sexuality; it is not merely the absence of disease, dysfunction and infirmity. Sexual health requires a posit...